Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $111.75 USD
Change Today +3.44 / 3.18%
Volume 935.2K
CLB On Other Exchanges
Symbol
Exchange
New York
Berlin
EN Amsterdam
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

core laboratories n.v. (CLB) Snapshot

Open
$107.75
Previous Close
$108.31
Day High
$113.16
Day Low
$106.73
52 Week High
09/4/14 - $160.67
52 Week Low
01/29/15 - $87.27
Market Cap
5.0B
Average Volume 10 Days
695.5K
EPS TTM
$4.65
Shares Outstanding
44.4M
EX-Date
07/15/15
P/E TM
24.0x
Dividend
$2.20
Dividend Yield
1.92%
Current Stock Chart for CORE LABORATORIES N.V. (CLB)

core laboratories n.v. (CLB) Related Bloomberg News

View More Bloomberg News

core laboratories n.v. (CLB) Related Businessweek News

No Related Businessweek News Found

core laboratories n.v. (CLB) Details

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the United States, Canada, and internationally. The company’s Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples. This segment offers analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. Its Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated services to evaluate the effectiveness of well completions and to develop solutions to enhance the effectiveness of enhanced oil recovery projects. The company’s Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase the production and improve recovery of oil and gas from its client’s reservoirs. It markets its products through sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

4,400 Employees
Last Reported Date: 07/27/15
Founded in 1936

core laboratories n.v. (CLB) Top Compensated Officers

Chairman of Supervisory Board, Chief Executiv...
Total Annual Compensation: $951.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $508.6K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $508.6K
Compensation as of Fiscal Year 2014.

core laboratories n.v. (CLB) Key Developments

Core Laboratories NV Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter, Fourth Quarter and Full Year of 2015

Core Laboratories NV announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company's revenue was $203.9 million compared with $267.6 million a year ago. Operating income was $47.9 million compared with $84.1 million a year ago. Income before income tax expense was $44.8 million compared with $81.3 million a year ago. Net income attributable to the company was $34.6 million or $0.81 per diluted share compared with $63.7 million or $1.42 per diluted share a year ago. The company reported operating income excluding specific items of $48.9 million, net income excluding specific items of $35.4 million or $0.82 per diluted share, net cash provided by operating activities of $46.7 million, and capital expenditures of $5.44 million. Capital expenditures for the quarter are $5.4 million, down from $12.1 million in the second quarter of 2014 in response to the current environment. Cash flow from operating activities in the quarter is $46.7 million. Free cash flow is $41.3 million for the quarter. For the six months, the company's revenue was $417.5 million compared with $530.5 million a year ago. Operating income was $90.6 million compared with $166.96 million a year ago. Income before income tax expense was $85.1 million compared with $161.8 million a year ago. Net income attributable to the company was $66.0 million or $1.53 per diluted share compared with $124.8 million or $2.77 per diluted share a year ago. The company reported cash flows from operating activities of $126.3 million and capital expenditures of $12.3 million. For the first half of the year, the company converted over 27% of revenues into free cash, which generated $114 million in free cash flow and represents 173% of net income. The company projects that third quarter revenue will range between $203,000,000 and $205,000,000, with EPS ranging between $0.82 and $0.84. Free cash flow for the third quarter 2015 is expected to exceed $50,000,000, significantly greater than projected net income. For the fourth quarter of 2015, the company projects revenue levels ranging from $205,000,000 to $210,000,000 with EPS ranging between $0.84 and $0.86. Free cash flow for the fourth quarter 2015 is expected to exceed $60,000,000. The company expect full year CapEx to be approximately $27 million in 2015, which is down about $10 million from 2014.

Core Laboratories N.V. Announces Third Quarter Cash Dividend Payable on 17 August 2015

The Board of Supervisory Directors of Core Laboratories N.V. has announced a cash dividend of $0.55 per share of common stock payable in the third quarter of 2015. The quarterly cash dividend will be payable on 17 August 2015, to shareholders of record on 17 July 2015. Dutch withholding tax will be deducted from the dividend at a rate of 15%.

Core Laboratories NV to Report Q2, 2015 Results on Jul 23, 2015

Core Laboratories NV announced that they will report Q2, 2015 results at 5:00 PM, W. Europe Standard Time on Jul 23, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLB:US $111.75 USD +3.44

CLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ALS Ltd A$5.40 AUD +0.48
Eurofins Scientific SE €292.25 EUR -0.25
Hunting PLC 518.00 GBp +27.60
Petroleum Geo-Services ASA 36.11 NOK +1.73
TGS Nopec Geophysical Co ASA 159.50 NOK +1.20
View Industry Companies
 

Industry Analysis

CLB

Industry Average

Valuation CLB Industry Range
Price/Earnings 24.6x
Price/Sales 4.9x
Price/Book 4,252.4x
Price/Cash Flow 21.1x
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORE LABORATORIES N.V., please visit www.corelab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.